These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30081064)

  • 1. (F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatch.
    Sullivan HC; Dean CL; Liwski RS; Biswas S; Goodman AL; Krummey S; Gebel HM; Bray RA
    Hum Immunol; 2018 Oct; 79(10):711-715. PubMed ID: 30081064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Rapid Optimized 96-well Tray Flow Cytometric Crossmatch (Halifax-FCXM) with Luminex Single Antigen Test.
    Yoo J; Lee S; Lee HW; Lee S; Choi J; Han J; Kang H; Choi A; Hee Jang J; Oh EJ
    Hum Immunol; 2021 Apr; 82(4):302-308. PubMed ID: 33744026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of virtual crossmatch (VXM) prediction of physical crossmatch (PXM) results of donor specific antibody (DSA) in routine pretransplant settings-a single-center experience.
    Olszowska-Zaremba N; Zagożdżon R; Gozdowska J
    Transpl Immunol; 2022 Jun; 72():101583. PubMed ID: 35314352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history?
    Tafulo S; Osório E; Mendes C; Liwski R
    Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
    Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
    Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive virtual crossmatch with negative flow crossmatch results in two cases.
    Jacob EK; De Goey SR; Gandhi MJ
    Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after flow cytometry crossmatch-positive lung transplants managed with perioperative desensitization.
    Aversa M; Kiernan J; Martinu T; Patriquin C; Barth D; Li Q; Huszti E; Ghany R; Cypel M; Keshavjee S; Singer LG; Tinckam K
    Am J Transplant; 2023 Nov; 23(11):1733-1739. PubMed ID: 37172694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation.
    Peng B; Zhuang Q; Yu M; Li J; Liu Y; Zhu L; Ming Y
    Med Sci Monit; 2019 Feb; 25():952-961. PubMed ID: 30712055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical application of the virtual crossmatch.
    Zangwill S; Ellis T; Stendahl G; Zahn A; Berger S; Tweddell J
    Pediatr Transplant; 2007 Sep; 11(6):650-4. PubMed ID: 17663689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
    Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
    Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation.
    Takakura K; Kiuchi T; Kasahara M; Uryuhara K; Uemoto S; Inomata Y; Tanaka K
    Clin Transplant; 2001 Oct; 15(5):309-16. PubMed ID: 11678956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multi-centric study to analyze pre-transplant compatibility algorithm for live-related donor kidney transplant in Indian setting: the "Delhi approach"!
    K Tiwari A; Handoo A; Choudhary M; Mehra S; Bacchas V; Yadav A; Negi A; Chopra R
    Transpl Immunol; 2021 Dec; 69():101487. PubMed ID: 34688882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes.
    Gandhi MJ; DeGoey SR; Bundy K; Kremers WK; Knauer R; Pereira N; Edwards B; Kushwaha S; Daly RC
    Transplant Proc; 2011 Dec; 43(10):3840-6. PubMed ID: 22172857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.
    Liwski RS; Greenshields AL; Conrad DM; Murphey C; Bray RA; Neumann J; Gebel HM
    Hum Immunol; 2018 Jan; 79(1):28-38. PubMed ID: 29109009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of complement-dependent cytotoxic and flow-cytometry crossmatch results before cadaveric kidney transplantation.
    Ayna TK; Soyöz M; Kurtulmuş Y; Doğan SM; Özyılmaz B; Tuğmen C; Pirim I
    Transplant Proc; 2013 Apr; 45(3):878-80. PubMed ID: 23622576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of rituximab on the T-cell flow cytometric crossmatch.
    Doss SA; Mittal S; Daniel D
    Transpl Immunol; 2021 Feb; 64():101360. PubMed ID: 33359130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of data-driven models for the flow cytometric crossmatch.
    Weimer ET; Newhall KA
    Hum Immunol; 2019 Dec; 80(12):983-989. PubMed ID: 31530432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations.
    Tambur AR; Ramon DS; Kaufman DB; Friedewald J; Luo X; Ho B; Skaro A; Caicedo J; Ladner D; Baker T; Fryer J; Gallon L; Miller J; Abecassis MM; Leventhal J
    Am J Transplant; 2009 Aug; 9(8):1886-93. PubMed ID: 19563341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual crossmatch for deceased donor kidney transplantation in the United States: A survey of histocompatibility lab directors and transplant surgeons.
    Puttarajappa CM; Tevar AD; Hoffman W; Degenholtz H; Schinstock CA; Gunabushanam V; Zeevi A; Xu Q; Hariharan S
    Hum Immunol; 2023 Mar; 84(3):214-223. PubMed ID: 36581507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High negative predictive value of an amplified flow cytometry crossmatch before living donor kidney transplantation.
    Lindemann M; Nyadu B; Heinemann FM; Kribben A; Paul A; Horn PA; Witzke O
    Hum Immunol; 2010 Aug; 71(8):771-6. PubMed ID: 20457201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.